GSTM1 and hypertensive disorder: In fact, as Gesualdo et al. [19] reported, in the post-TREAT era, investigators in the MONITOR-CKD5 study claimed to have a theoretical target Hb range for patients with (lower target) and without (higher target) such risk factors as hypertension, cardiovascular disease, history of stroke, diabetes, prior cancer, or being elderly.